Attending ARCS this year? We'll be there! And, we’d love to chat about optimising your clinical trials with best-in-class digital tools. ObvioHealth has global expertise and a wide range of tech-enabled services to generate the strong therapeutic evidence you need.
Tune in as Taylor Major outlines the current state of play for successfully enrolling participants via social media in Australia. They will discuss lessons learned from social media recruitment and share a case study on a highly successful U.S. campaign, with implications for adapting to Australian laws, ethical standards, and cultural norms.
Learn how ObvioHealth is leveraging digital platform capabilities to design and run decentralised and hybrid trials that capture patient data in near real time. See how our virtual site team monitors compliance and safety data to maintain patient engagement while delivering more accurate and safer trials.
Fill out the form below to schedule a meeting with our team of APAC clinical operations experts.
Taylor Major has been at the forefront of optimising decentralised clinical trials (DCTs) for ObvioHealth in APAC, leveraging 10 years of experience in the medical research and clinical science fields to support increased access to clinical trials for all patients through eHealth technologies.
Neil Smith has spent over 25 years bringing operational leadership and expertise to some of the world’s largest CROs—including IQVIA, PPD, Novartis, and ICON. Neil continues to lead at ObvioHealth, applying his deep-rooted clinical expertise to deliver better patient experiences, more efficient workflows, and stronger evidence for clients in the APAC region.
Admir Huseincehajic is a patient recruitment and study coordination expert who’s been developing transformative healthcare applications, managing clinical data, and optimising trial experiences from study start-up to close-out for over 20 years.
ObvioHealth is a pioneering virtual research organization (VRO). Over the past six years, we’ve conducted more than 60 decentralised clinical trials across continents and industry sectors that delivered strong evidence for regulatory approvals. Our formula for successful clinical trials incorporates a range of differentiating capabilities—all designed to optimise studies no matter where in the world they’re conducted.